Notice
본문 바로가기
메인메뉴
Company
About Qurient
History
Management
Contact Us
Business Philosophy
Pipeline
Pipeline
Q901
Adrixetinib (Q702)
Q301
Telacebec (Q203)
5-Lipoxygenase Inhibitor
QLi5 Therapeutics
Clinical Trials
Clinical Trials
IR / PR
Notice
Press Release
Qurient in the news
Financial
Disclosure
Blog
WEBTOON
WEBTOON
Company
Pipeline
Clinical Trials
IR / PR
WEBTOON
Company
Pipeline
Clinical Trials
IR / PR
WEBTOON
Notice
Press Release
Qurient in the news
Financial
Disclosure
Blog
Notice
Press Release
Qurient in the news
Financial
Disclosure
Blog
Notice
주식액면분할에 따른 구주권 제출 공고
페이지 정보
Author
QURIENT
Date
2015-09-01 11:15
Views
14,257
본문
Prev
Next
List
information for download file
* Name
Company
Phone
* Business e-mail
Comment
Request Download
팝업 닫기
Notice